NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis.

Author(s): Winkel BG, Hollegaard MV, Olesen MS, Svendsen JH, Haunsø S, Hougaard DM, Tfelt-Hansen J

Publication: BMC Med Genet, 2011, Vol. 12, Page 22

PubMed ID: 21306642 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if whole genome amplified (WGA) DNA from dried blood spots (DBS) stored at -20 degrees C for 19-28 years have comparable melting curves and sequencing results to fresh liquid blood specimens from patients with atrial fibrillation.

Conclusion of Paper

Melting curve analysis of 40 amplicons in 10 patients revealed 85 (21%) and 81 (20%) alterations from wild-type using WGA-DBS DNA and fresh genomic DNA, respectively. Although, 64% and 62% of the alterations using WGA-DBS and fresh blood, respectively, were determined to be false positives after sequencing. By sequencing, the same 31 variants were identified using DNA from WGA-DBS and fresh DNA.

Studies

  1. Study Purpose

    The purpose of this study was to determine if WGA-DBS stored frozen for 19-28 years have comparable melting curves and sequencing results to fresh blood specimens from patients with atrial fibrillation. DBS obtained at patient birth were stored at -20 degrees C for 19-28 years. DNA was extracted from DBS by Extract-N-amp Blood PCR Kit and amplified with REPLI-g. Fresh blood was obtained from the same patients, and DNA was extracted using the QIAamp mini blood kit. Melting curves were evaluated by high resolution melting curve analysis.

    Summary of Findings:

    Melting curve analysis of 40 amplicons in 10 patients revealed 85 (21%) and 81 (20%) alterations from wild-type using WGA-DBS DNA and fresh genomic DNA, respectively. Although, 64% and 62% of the alterations using WGA-DBS and fresh blood, respectively, were determined to be false positives after sequencing. By sequencing, the same 31 variants were identified using DNA from WGA-DBS and fresh DNA and included 29 heterogeneous and 2 homogeneous changes.

    Biospecimens
    Preservative Types
    • Other Preservative
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Cardiovascular Disease
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    DNA DNA sequencing
    DNA SNP assay
    DNA Whole genome amplification
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Air-dried
    None (fresh)
    Frozen
    Storage Storage duration 0 days
    19-28 years
    Analyte Extraction and Purification Analyte isolation method QIAamp mini kit
    Extract-N-amp Blood PCR Kit
    SNP assay Specific Targeted nucleic acid SCN5A
    KCNA5
    SNP assay Specific Nucleic acid amplification None
    REPLI-g
    Preaquisition Diagnosis/ patient condition Atrial fibrillation
    SNP assay Specific Technology platform High resolution melting curve analysis
    DNA sequencing

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...